Recurrence in meningeal hemangiopericytomas

Surg Neurol. 1998 Dec;50(6):586-91. doi: 10.1016/s0090-3019(98)00043-3.

Abstract

Background: Meningeal hemangiopericytomas are more aggressive than typical meningiomas, with a high rate of recurrence and distant metastases. The question of whether a correlation exists between prognosis and histologic features remains controversial.

Case description: We report two cases of recurrent meningeal hemangiopericytomas. Although local growth control of the tumor was obtained by tumor removal and irradiation in a 38-year-old male patient (Case 1) with a recurrent tentorial tumor, the tumor disseminated and metastasized extracranially within a short period after treatment, leading to rapid deterioration. Another 38-year-old female patient (Case 2) with a recurrent orbital tumor had a favorable outcome after tumor removal. The Ki-67 proliferative index using the MIB-1 monoclonal antibody increased as the tumor recurred in Case 1 (2.5%, 7.9%, and 15.7%), but did not change between primary and recurrent tumors of Case 2 (4.2%, 3.1%). Immunostaining for p53 protein in Case 1 was negative at the first resection, and became positive at the second and third resections, whereas in Case 2, it was negative in both the primary and recurrent tumors.

Conclusions: Our results suggest that p53 protein accumulation with a high proliferative potential is a useful marker to estimate malignant progression in meningeal hemangiopericytomas.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain Neoplasms / secondary
  • Disease Progression
  • Female
  • Genes, p53 / genetics
  • Hemangiopericytoma / chemistry
  • Hemangiopericytoma / genetics
  • Hemangiopericytoma / secondary*
  • Humans
  • Lung Neoplasms / secondary
  • Male
  • Meningeal Neoplasms / chemistry
  • Meningeal Neoplasms / genetics
  • Meningeal Neoplasms / pathology*
  • Mutation
  • Predictive Value of Tests
  • Prognosis
  • Spinal Neoplasms / secondary
  • Tumor Suppressor Protein p53 / analysis*
  • Vascular Neoplasms / secondary

Substances

  • Tumor Suppressor Protein p53